The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina Pectoris
NCT00135850
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Heart Disease
Interventions
GENETIC:
VEGF-A165 plasmid
Sponsor
Rigshospitalet, Denmark